Pricing Log in Create free account

Assembly Biosciences, Inc. (ASMB) vs C4 Therapeutics, Inc. (CCCC)

Assembly Biosciences, Inc. and C4 Therapeutics, Inc. are both Biotechnology companies. Assembly Biosciences, Inc. and C4 Therapeutics, Inc. are of similar size ($405.6M and $394.9M). Assembly Biosciences, Inc. grew revenue faster over the last twelve months: 125.1% against 2.33%. Assembly Biosciences, Inc. has the higher net margin (−0.06% vs −289.4%) and the higher return on invested capital (0.00% vs 0.00%). Across the 15 metrics below, Assembly Biosciences, Inc. leads on 14 and C4 Therapeutics, Inc. on 1.

Valuation

Metric ASMB CCCC Biotechnology median
P/E n/m n/m 10.64
P/S 5.04 11.86 9.59
P/B 1.23 1.68 2.15
Price to free cash flow n/m n/m 26.07
EV/EBITDA n/m n/m 0.65
EV/Sales 0.76 5.16 9.45
Earnings yield (0.80%) (31.45%) (34.69%)
Free cash flow yield (10.23%) (20.55%) (24.02%)

Profitability

Metric ASMB CCCC Biotechnology median
Gross margin 100.00% 100.00% 65.59%
Operating margin (11.75%) (318.97%) 0.00%
Net margin (0.06%) (289.44%) 0.00%
Free cash flow margin (51.53%) (243.71%) 0.00%
Return on equity (0.03%) (48.14%) (51.96%)
Return on assets (0.02%) (30.92%) (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric ASMB CCCC Biotechnology median
Revenue growth (TTM) 125.12% 2.33% 4.59%
EPS growth (last fiscal year) 91.78% 16.45% 29.88%
Revenue growth, 5-year CAGR 35.27% 1.61% 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ASMB CCCC Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 13.99 5.45 4.86
Net debt to EBITDA 17.31 2.14 1.01

Dividend

Metric ASMB CCCC Biotechnology median
Dividend yield — — 0.38%
Payout ratio — — —

Size

Metric ASMB CCCC Biotechnology median
Market cap 405.59m 394.91m 174.29m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack